K. Stuart, N. Houssami, R. Taylor, A. Hayen, and J. Boyages, Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis, BMC Cancer, vol.28, issue.4, p.890, 2015.
DOI : 10.1200/JCO.2009.26.8847

K. Kerlikowske, A. Molinaro, M. Gauthier, H. Berman, F. Waldman et al., Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis, JNCI Journal of the National Cancer Institute, vol.102, issue.9, pp.627-664, 2010.
DOI : 10.1093/jnci/djq101

A. Molinaro, J. Sison, B. Ljung, T. Tlsty, and K. Kerlikowske, Risk prediction for local versus regional/metastatic tumors after initial ductal carcinoma in situ diagnosis treated by lumpectomy, Breast Cancer Research and Treatment, vol.302, issue.151, pp.351-61, 2016.
DOI : 10.1001/jama.2009.1498

C. Tunon-de-lara, M. Chauvet, M. Baranzelli, M. Baron, J. Piquenot et al., The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study, Annals of Surgical Oncology, vol.72, issue.12, pp.3853-60, 2015.
DOI : 10.1158/0008-5472.CAN-12-0636

I. De-mascarel, G. Macgrogan, S. Mathoulin-pélissier, I. Soubeyran, V. Picot et al., Breast ductal carcinoma in situ with microinvasion, Cancer, vol.7, issue.8, pp.2134-2176, 2002.
DOI : 10.1097/00125480-200007020-00005

S. Bannani, S. Rouquette, C. Bendavid-athias, P. Tas, and J. Levêque, The locoregional recurrence post-mastectomy for ductal carcinoma in situ: Incidence and risk factors, The Breast, vol.24, issue.5, pp.608-620, 2015.
DOI : 10.1016/j.breast.2015.06.005

URL : https://hal.archives-ouvertes.fr/hal-01187429

L. Kelley, M. Silverstein, and L. Guerra, Analyzing the Risk of Recurrence after Mastectomy for DCIS: A New Use for the USC/Van Nuys Prognostic Index, Annals of Surgical Oncology, vol.72, issue.24, pp.459-62, 2011.
DOI : 10.1016/j.ijrobp.2008.06.482

D. Owen, S. Tyldesley, C. Alexander, C. Speers, P. Truong et al., Outcomes in Patients Treated With Mastectomy for Ductal Carcinoma In Situ, International Journal of Radiation Oncology*Biology*Physics, vol.85, issue.3, pp.129-134, 2013.
DOI : 10.1016/j.ijrobp.2012.10.020

A. Mushawah, F. Rastelli, A. Pluard, T. Margenthaler, and J. , Metastatic Invasive Breast Cancer Recurrence Following Curative-Intent Therapy for Ductal Carcinoma In Situ, Journal of Surgical Research, vol.173, issue.1, pp.10-15, 2012.
DOI : 10.1016/j.jss.2011.04.058

S. Narod, J. Iqbal, V. Giannakeas, V. Sopik, and P. Sun, Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ, JAMA Oncology, vol.1, issue.7, pp.888-96, 2015.
DOI : 10.1001/jamaoncol.2015.2510

V. Ernster, J. Barclay, K. Kerlikowske, H. Wilkie, and R. Ballard-barbash, Mortality Among Women With Ductal Carcinoma In Situ of the Breast in the Population-Based Surveillance, Epidemiology and End Results Program, Archives of Internal Medicine, vol.160, issue.7, pp.953-961, 2000.
DOI : 10.1001/archinte.160.7.953

M. Donker, S. Litière, G. Werutsky, J. Julien, I. Fentiman et al., Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial, Journal of Clinical Oncology, vol.31, issue.32, pp.4054-4063, 2013.
DOI : 10.1200/JCO.2013.49.5077

I. Wapnir, J. Dignam, B. Fisher, E. Mamounas, S. Anderson et al., Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS, JNCI Journal of the National Cancer Institute, vol.103, issue.6, pp.478-88, 2011.
DOI : 10.1093/jnci/djr027

Y. Fang, J. Wu, W. Wang, X. Fei, Y. Zong et al., Biologic behavior and long-term outcomes of breast ductal carcinoma <i>in situ</i> with microinvasion, Oncotarget, vol.7, issue.39, pp.64182-90, 2016.
DOI : 10.18632/oncotarget.11639

C. Vieira, C. Mercado, J. Cangiarella, L. Moy, H. Toth et al., Microinvasive ductal carcinoma in situ: Clinical presentation, imaging features, pathologic findings, and outcome, European Journal of Radiology, vol.73, issue.1, pp.102-109, 2010.
DOI : 10.1016/j.ejrad.2008.09.037

M. Brennan, R. Turner, S. Ciatto, M. Marinovich, J. French et al., Ductal Carcinoma in Situ at Core-Needle Biopsy: Meta-Analysis of Underestimation and Predictors of Invasive Breast Cancer, Radiology, vol.260, issue.1, pp.119-147, 2011.
DOI : 10.1148/radiol.11102368

N. Houssami, S. Ciatto, I. Ellis, and D. Ambrogetti, Underestimation of malignancy of breast coreneedle biopsy: concepts and precise overall and category-specific estimates, Cancer. 1 févr, vol.109, issue.3, pp.487-95, 2007.

P. Ananian, G. Houvenaeghel, C. Protière, P. Rouanet, S. Arnaud et al., Determinants of Patients? Choice of Reconstruction with Mastectomy for Primary Breast Cancer, Annals of Surgical Oncology, vol.20, issue.8, pp.762-71, 2004.
DOI : 10.1245/ASO.2004.11.027

N. Ilonzo, A. Tsang, S. Tsantes, A. Estabrook, T. Ma et al., Breast reconstruction after mastectomy: A ten-year analysis of trends and immediate postoperative outcomes, The Breast, vol.32, pp.7-12, 2017.
DOI : 10.1016/j.breast.2016.11.023

L. Kruper, X. Xu, K. Henderson, and L. Bernstein, Disparities in Reconstruction Rates after Mastectomy for Ductal Carcinoma in Situ (DCIS): Patterns of Care and Factors Associated with the Use of Breast Reconstruction for DCIS Compared with Invasive Cancer, Annals of Surgical Oncology, vol.3, issue.11, pp.3210-3219, 2011.
DOI : 10.1007/BF02305667

P. Burnier, D. Hudry, L. See, A. Duvernay, M. Roche et al., Patient age and breast resection weight affect immediate postmastectomy breast reconstruction in ductal carcinoma in situ, Journal of Plastic, Reconstructive & Aesthetic Surgery, vol.69, issue.1, pp.37-41, 2016.
DOI : 10.1016/j.bjps.2015.09.023

URL : https://hal.archives-ouvertes.fr/hal-01577018

I. Naoura, C. Mazouni, J. Ghanimeh, N. Leymarie, J. Garbay et al., Factors influencing the decision to offer immediate breast reconstruction after mastectomy for ductal carcinoma in situ (DCIS): The Institut Gustave Roussy Breast Cancer Study Group experience, The Breast, vol.22, issue.5, pp.673-678, 2013.
DOI : 10.1016/j.breast.2013.01.002

L. Stevens, M. Mcgrath, R. Druss, S. Kister, F. Gump et al., The Psychological Impact of Immediate Breast Reconstruction for Women with Early Breast Cancer, Plastic and Reconstructive Surgery, vol.73, issue.4, pp.619-647, 1984.
DOI : 10.1097/00006534-198404000-00018

K. Yu, L. Wu, G. Liu, J. Wu, G. Di et al., Different Distribution of Breast Cancer Subtypes in Breast Ductal Carcinoma in situ (DCIS), DCIS with Microinvasion, and DCIS with Invasion Component, Annals of Surgical Oncology, vol.15, issue.5, pp.1342-1350, 2011.
DOI : 10.1097/01.MP.0000038462.62634.B1

W. Zhang, E. Gao, Y. Zhou, Q. Zhai, Z. Zou et al., Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer, World J Surg Oncol, vol.10, p.262, 2012.

S. Leitner, A. Swern, D. Weinberger, L. Duncan, and R. Hutter, Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a,b N0 M0), Cancer. 1 déc, vol.76, issue.11, pp.2266-74, 1995.

G. Canavese, P. Bruzzi, A. Catturich, C. Vecchio, D. Tomei et al., Intra-operative evaluation of the sentinel lymph node for T1-N0 breast-cancer patients: Always or never? A risk/benefit and cost/benefit analysis, European Journal of Surgical Oncology (EJSO), vol.36, issue.8, pp.737-781, 2010.
DOI : 10.1016/j.ejso.2010.06.010

URL : https://hal.archives-ouvertes.fr/hal-00608926

G. Houvenaeghel, A. Goncalves, J. Classe, J. Garbay, S. Giard et al., Characteristics and clinical outcome of T1 breast cancer: a multicenter retrospective cohort study, Annals of Oncology, vol.25, issue.3, pp.623-631, 2014.
DOI : 10.1093/annonc/mdt532

M. Dieterich, F. Hartwig, J. Stubert, S. Klöcking, G. Kundt et al., Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival, The Breast, vol.23, issue.4, pp.346-51, 2014.
DOI : 10.1016/j.breast.2014.01.015

A. Logullo, A. Godoy, M. Mourão-neto, A. Simpson, I. Nishimoto et al., Presence of ductal carcinoma in situ confers an improved prognosis for patients with T1N0M0 invasive breast carcinoma, Brazilian Journal of Medical and Biological Research, vol.28, issue.8, pp.913-922, 2002.
DOI : 10.1016/S0959-8049(05)80117-0

C. Cedolini, S. Bertozzi, A. Londero, L. Seriau, M. Andretta et al., Impact of the presence and quantity of ductal carcinoma in situ component on the outcome of invasive breast cancer, Int J Clin Exp Pathol, vol.8, issue.10, pp.13304-13317, 2015.

S. Kinsey-trotman, Z. Shi, and B. Fosh, Breast ductal carcinoma in situ: a literature review of adjuvant hormonal therapy, Oncology Reviews, vol.10, issue.2, p.304, 2016.
DOI : 10.4081/oncol.2016.304

B. Fisher, S. Land, E. Mamounas, J. Dignam, E. Fisher et al., Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project experience, Seminars in Oncology, vol.28, issue.4, pp.400-418, 2001.
DOI : 10.1016/S0093-7754(01)90133-2

J. Cuzick, I. Sestak, S. Pinder, I. Ellis, S. Forsyth et al., Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial, The Lancet Oncology, vol.12, issue.1, pp.21-30, 2011.
DOI : 10.1016/S1470-2045(10)70266-7

B. Sprague, V. Mclaughlin, J. Hampton, P. Newcomb, and A. Trentham-dietz, Disease-free survival by treatment after a DCIS diagnosis in a population-based cohort study, Breast Cancer Research and Treatment, vol.2010, issue.41, pp.145-54, 2013.
DOI : 10.1093/jncimonographs/lgq029

J. Cuzick, I. Sestak, J. Forbes, M. Dowsett, J. Knox et al., Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial, The Lancet, vol.383, issue.9922, pp.1041-1049, 2014.
DOI : 10.1016/S0140-6736(13)62292-8

P. Goss, J. Ingle, J. Alés-martínez, A. Cheung, R. Chlebowski et al., Exemestane for Breast-Cancer Prevention in Postmenopausal Women, New England Journal of Medicine, vol.364, issue.25, pp.2381-91, 2011.
DOI : 10.1056/NEJMoa1103507

S. Al-himdani, S. Timbrell, K. Tan, J. Morris, and N. Bundred, Prediction of margin involvement and local recurrence after skin-sparing and simple mastectomy, European Journal of Surgical Oncology (EJSO), vol.42, issue.7, pp.935-976, 2016.
DOI : 10.1016/j.ejso.2016.04.055

M. Chadha, J. Portenoy, S. Boolbol, A. Gillego, and L. Harrison, Is there a role for postmastectomy radiation therapy in ductal carcinoma in situ, Int J Surg Oncol, vol.2012, p.423520, 2012.

L. Chan, J. Rabban, E. Hwang, A. Bevan, M. Alvarado et al., Is Radiation Indicated in Patients With Ductal Carcinoma In Situ and Close or Positive Mastectomy Margins?, International Journal of Radiation Oncology*Biology*Physics, vol.80, issue.1, pp.25-30, 2011.
DOI : 10.1016/j.ijrobp.2010.01.044

A. Rashtian, S. Iganej, A. Liu, I. Natarajan, and S. , Close or Positive Margins After Mastectomy for DCIS: Pattern of Relapse and Potential Indications for Radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.72, issue.4, pp.1016-1036, 2008.
DOI : 10.1016/j.ijrobp.2008.06.1954

K. Williams, N. Barnes, A. Cramer, R. Johnson, K. Cheema et al., Molecular phenotypes of DCIS predict overall and invasive recurrence, Annals of Oncology, vol.26, issue.5, pp.1019-1044, 2015.
DOI : 10.1093/annonc/mdv062

Y. Belkacémi, A. Fourquet, B. Cutuli, C. Bourgier, M. Hery et al., Radiotherapy for invasive breast cancer: Guidelines for clinical practice from the French expert review board of Nice/Saint-Paul de Vence, Critical Reviews in Oncology/Hematology, vol.79, issue.2, pp.91-102, 2011.
DOI : 10.1016/j.critrevonc.2010.06.002

M. Voordeckers, J. Van-de-steene, V. Vinh-hung, and G. Storme, Adjuvant radiotherapy after mastectomy for pT1???pT2 node negative (pN0) breast cancer: is it worth the effort?, Radiotherapy and Oncology, vol.68, issue.3, pp.227-258, 2003.
DOI : 10.1016/S0167-8140(03)00234-2

N. Rowell, Radiotherapy to the chest wall following mastectomy for node-negative breast cancer: A systematic review, Radiotherapy and Oncology, vol.91, issue.1, pp.23-32, 2009.
DOI : 10.1016/j.radonc.2008.09.026

P. Truong, I. Olivotto, H. Kader, M. Panades, C. Speers et al., Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.61, issue.5, pp.1337-1384, 2005.
DOI : 10.1016/j.ijrobp.2004.08.009

C. Huang, M. Hou, H. Chuang, S. Lian, M. Huang et al., Comparison of Clinical Outcome of Breast Cancer Patients with T1-2 Tumor and One to Three Positive Nodes with or without Postmastectomy Radiation Therapy, Japanese Journal of Clinical Oncology, vol.42, issue.8, pp.711-731, 2012.
DOI : 10.1093/jjco/hys080

A. Recht, E. Comen, R. Fine, G. Fleming, P. Hardenbergh et al., Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update, Practical Radiation Oncology, vol.6, issue.6, pp.219-253, 2016.
DOI : 10.1016/j.prro.2016.08.009

R. Wolters, F. Ebner, W. Janni, I. Novopashenny, A. Wöckel et al., Do T1a breast cancers profit from adjuvant systemic therapy? A multicenter retrospective cohort study of 325

C. Tunon-de-lara, G. André, G. Macgrogan, J. Dilhuydy, J. Bussières et al., Ductal Carcinoma In Situ of the Breast: Influence of Age on Diagnostic, Therapeutic, and Prognostic Features. Retrospective Study of 812 Patients, Annals of Surgical Oncology, vol.48, issue.5, pp.1372-1381, 2011.
DOI : 10.1016/S0360-3016(00)00715-X

L. Elshof, M. Schaapveld, M. Schmidt, E. Rutgers, F. Van-leeuwen et al., Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women, Breast Cancer Research and Treatment, vol.51, issue.32, pp.553-63, 2016.
DOI : 10.1016/j.ejca.2015.05.008

L. Wang, W. Zhang, S. Lyu, X. Liu, T. Zhang et al., Clinicopathologic characteristics and molecular subtypes of microinvasive carcinoma of the breast, Tumor Biology, vol.23, issue.4, pp.2241-2249, 2015.
DOI : 10.1200/JCO.2005.08.001

J. Hastings, S. Iganej, C. Huang, R. Huang, and J. Slezak, Risk Factors for Locoregional Recurrence After Mastectomy in Stage T1 N0 Breast Cancer, American Journal of Clinical Oncology, vol.37, issue.5, pp.486-91, 2014.
DOI : 10.1097/COC.0b013e31827e54c2

Y. Cihan and T. Sarigoz, Role of post mastectomy radiation therapy in breast cancer patients with T1&ndash;2 and 1&ndash;3 positive lymph nodes, OncoTargets and Therapy, vol.9, pp.5587-95, 2016.
DOI : 10.2147/OTT.S106871

J. Davis, B. Nemesure, S. Mehmood, V. Nayi, S. Burke et al., Her2 and Ki67 Biomarkers Predict Recurrence of Ductal Carcinoma in Situ, Applied Immunohistochemistry & Molecular Morphology, vol.24, issue.1, pp.20-25, 2016.
DOI : 10.1097/PAI.0000000000000223

S. Lari and H. Kuerer, Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review, Journal of Cancer, vol.2, pp.232-61, 2011.
DOI : 10.7150/jca.2.232

N. Poulakaki, G. Makris, M. Battista, D. Böhm, K. Petraki et al., Hormonal receptor status, Ki-67 and HER2 expression: Prognostic value in the recurrence of ductal carcinoma in situ of the breast?, The Breast, vol.25, pp.57-61, 2016.
DOI : 10.1016/j.breast.2015.10.007

K. Han, S. Nofech-mozes, S. Narod, W. Hanna, D. Vesprini et al., Expression of HER2neu in Ductal Carcinoma in situ is Associated with Local Recurrence, Clinical Oncology, vol.24, issue.3, pp.183-192, 2012.
DOI : 10.1016/j.clon.2011.09.008

P. Holmes, J. Lloyd, I. Chervoneva, E. Pequinot, D. Cornfield et al., Prognostic markers and long-term outcomes in ductal carcinoma in situ of the breast treated with excision alone, Cancer, vol.67, issue.16, pp.3650-3657, 2011.
DOI : 10.1158/0008-5472.CAN-06-4038

M. Gauthier, H. Berman, C. Miller, K. Kozakeiwicz, K. Chew et al., Abrogated Response to Cellular Stress Identifies DCIS Associated with Subsequent Tumor Events and Defines Basal-like Breast Tumors, Cancer Cell, vol.12, issue.5, pp.479-91, 2007.
DOI : 10.1016/j.ccr.2007.10.017

K. Jirström, A. Ringberg, M. Fernö, L. Anagnostaki, and G. Landberg, Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence, British Journal of Cancer, vol.89, issue.10, pp.1920-1926, 2003.
DOI : 10.1038/sj.bjc.6601398

M. Lazzeroni, B. Dunn, G. Pruneri, B. Jereczek-fossa, R. Orecchia et al., Adjuvant therapy in patients with ductal carcinoma in situ of the breast: The Pandora???s box, Cancer Treatment Reviews, vol.55, pp.1-9, 2017.
DOI : 10.1016/j.ctrv.2017.01.010

S. Childs, Y. Chen, M. Duggan, M. Golshan, S. Pochebit et al., Impact of Margin Status on Local Recurrence After Mastectomy for Ductal Carcinoma In Situ, 948?52. REFERENCES 1. Seradour B. Breast cancer screening in France: an overview, pp.191-200, 2009.
DOI : 10.1016/j.ijrobp.2012.07.2377

N. Baxter, B. Virnig, and S. Durham, Trends in the Treatment of Ductal Carcinoma In Situ of the Breast, JNCI Journal of the National Cancer Institute, vol.96, issue.6, pp.443-451, 2004.
DOI : 10.1093/jnci/djh069

F. Dominguez, M. Golshan, and D. Black, Sentinel Node Biopsy is Important in Mastectomy for Ductal Carcinoma In Situ, Annals of Surgical Oncology, vol.10, issue.1
DOI : 10.1245/s10434-007-9610-6

C. Allegra, D. Aberle, and P. Ganschow, National Institutes of Health State-of-the-Science Conference Statement: diagnosis and management of ductal carcinoma in situ, 2009.

B. Smith, Clinical applications of breast pathology: management of in situ breast carcinomas and sentinel node biopsy issues, Modern Pathology, vol.14, pp.33-38, 2010.
DOI : 10.1245/ASO.2005.05.004

R. Mansel, L. Fallowfield, and M. Kissin, Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial, JNCI: Journal of the National Cancer Institute, vol.98, issue.9, pp.599-609, 2006.
DOI : 10.1093/jnci/djj158

U. Veronesi, G. Viale, and G. Paganelli, Sentinel Lymph Node Biopsy in Breast Cancer, Annals of Surgery, vol.251, issue.4, pp.595-600, 2010.
DOI : 10.1097/SLA.0b013e3181c0e92a

A. Giuliano, K. Hunt, and K. Ballman, Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis, JAMA, vol.305, issue.6, pp.569-75, 2011.
DOI : 10.1001/jama.2011.90

J. Rodier, M. Velten, and M. Wilt, Prospective Multicentric Randomized Study Comparing Periareolar and Peritumoral Injection of Radiotracer and Blue Dye for the Detection of Sentinel Lymph Node in Breast Sparing Procedures: FRANSENODE Trial, Journal of Clinical Oncology, vol.25, issue.24, pp.3664-3673, 2007.
DOI : 10.1200/JCO.2006.08.4228

A. Wolff, M. Hammond, and J. Schwartz, American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer, Journal of Clinical Oncology, vol.25, issue.1, pp.118-163, 2007.
DOI : 10.1200/JCO.2006.09.2775

M. De-roos, B. Van-der-vegt, and J. Peterse, The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome in ?pure? ductal carcinoma in situ of the breast, Histopathology, vol.10, issue.2, pp.227-265, 2007.
DOI : 10.1038/nrc1251

K. Kerlikowske, A. Molinaro, and M. Gauthier, Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis, JNCI Journal of the National Cancer Institute, vol.102, issue.9, pp.627-664, 2010.
DOI : 10.1093/jnci/djq101

C. Cox, S. Pendas, and J. Cox, Guidelines for Sentinel Node Biopsy and Lymphatic Mapping of Patients With Breast Cancer, Annals of Surgery, vol.227, issue.5
DOI : 10.1097/00000658-199805000-00005

M. Brennan, R. Turner, and S. Ciatto, Ductal Carcinoma in Situ at Core-Needle Biopsy: Meta-Analysis of Underestimation and Predictors of Invasive Breast Cancer, Radiology, vol.260, issue.1, pp.119-147, 2011.
DOI : 10.1148/radiol.11102368

L. Huo, N. Sneige, and K. Hunt, Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ, Cancer, vol.50, issue.8, pp.1760-1768, 2006.
DOI : 10.1016/S0039-6109(16)45185-6

T. Yen, K. Hunt, and M. Ross, Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: A guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ, Journal of the American College of Surgeons, vol.200, issue.4, pp.516-542, 2005.
DOI : 10.1016/j.jamcollsurg.2004.11.012

J. Han, K. Molberg, and V. Sarode, Predictors of Invasion and Axillary Lymph Node Metastasis in Patients with a Core Biopsy Diagnosis of Ductal Carcinoma In Situ: An Analysis of 255 Cases, The Breast Journal, vol.6, issue.3, pp.223-232, 2011.
DOI : 10.1046/j.1524-4741.2000.20002.x

J. Kim, W. Han, and J. Lee, Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision, The Breast, vol.21, issue.5, pp.641-646, 2012.
DOI : 10.1016/j.breast.2012.06.012

C. Moran, M. Kell, and F. Flanagan, Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients, The American Journal of Surgery, vol.194, issue.2, pp.172-177, 2007.
DOI : 10.1016/j.amjsurg.2006.11.027

C. Trentin, V. Dominelli, and P. Maisonneuve, Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: Experience of 733 cases, The Breast, vol.21, issue.5, pp.635-675, 2012.
DOI : 10.1016/j.breast.2012.06.009

V. Galimberti, B. Cole, and S. Zurrida, Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23???01): a phase 3 randomised controlled trial, The Lancet Oncology, vol.14, issue.4, pp.297-305, 2013.
DOI : 10.1016/S1470-2045(13)70035-4

M. Leidenius, K. Salmenkivi, and K. Von-smitten, Tumour-positive sentinel node findings in patients with ductal carcinoma in situ, Journal of Surgical Oncology, vol.12, issue.5, pp.380-384, 2006.
DOI : 10.1002/jso.20581

H. Mabry, A. Giuliano, and M. Silverstein, What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ?, The American Journal of Surgery, vol.192, issue.4, pp.455-462, 2006.
DOI : 10.1016/j.amjsurg.2006.06.028

T. Meretoja, . Heikkila¨psheikkila¨ps, and K. Salmenkivi, Outcome of Patients with Ductal Carcinoma In Situ and Sentinel Node Biopsy, Annals of Surgical Oncology, vol.207, issue.7
DOI : 10.1016/j.jamcollsurg.2008.06.139

K. Tada, A. Ogiya, and K. Kimura, Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer, World Journal of Surgical Oncology, vol.8, issue.1, pp.319-344, 2010.
DOI : 10.1186/1477-7819-8-6

C. Tunon-de-lara, S. Giard, and M. Buttarelli, Sentinel Node Procedure is Warranted in Ductal Carcinoma In Situ with High Risk of Occult Invasive Carcinoma and Microinvasive Carcinoma Treated by Mastectomy, The Breast Journal, vol.55, issue.2, pp.135-175, 2008.
DOI : 10.1200/JCO.2005.03.3225

G. Houvenaeghel, C. Nos, and H. Mignotte, Micrometastases in Sentinel Lymph Node in a Multicentric Study: Predictive Factors of Nonsentinel Lymph Node Involvement???Groupe Des Chirurgiens De La Federation Des Centres De Lutte Contre Le Cancer, Journal of Clinical Oncology, vol.24, issue.12, pp.1814-1822, 2006.
DOI : 10.1200/JCO.2005.03.3225

M. Yi, S. Krishnamurthy, and H. Kuerer, Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer, The American Journal of Surgery, vol.196, issue.1, pp.81-88, 2008.
DOI : 10.1016/j.amjsurg.2007.08.057

S. Bendifallah, N. Chabbert-buffet, and N. Maurin, Predictive factors for breast cancer in patients diagnosed with ductal intraepithelial neoplasia, grade 1B, Anticancer Res, vol.32, pp.3571-3580, 2012.

N. Houssami, D. Ambrogetti, and M. Marinovich, Accuracy of a Preoperative Model for Predicting Invasive Breast Cancer in Women with Ductal Carcinoma-in-situ on Vacuum-Assisted Core Needle Biopsy, Annals of Surgical Oncology, vol.8, issue.5, pp.1364-71, 2011.
DOI : 10.1016/S1470-2045(07)70278-4

S. Nishimura, K. Takahashi, and N. Gomi, What is the predictor for invasion in nonpalpable breast cancer with microcalcifications? Breast Cancer, pp.49-54, 2004.

Y. Suh, M. Kim, and E. Kim, 8- or 11-gauge vacuum-assisted biopsy, The British Journal of Radiology, vol.85, issue.1016, pp.349-56, 2012.
DOI : 10.1259/bjr/30974918

J. Tan, D. Mccready, and A. Easson, Role of Sentinel Lymph Node Biopsy in Ductal Carcinoma-in-situ Treated by Mastectomy, Annals of Surgical Oncology, vol.98, issue.2, pp.638-683, 2007.
DOI : 10.1038/bjc.1992.230

L. Chin-lenn, L. Mack, and W. Temple, Predictors of Treatment with Mastectomy, Use of Sentinel Lymph Node Biopsy and Upstaging to Invasive Cancer in Patients Diagnosed with Breast Ductal Carcinoma In situ (DCIS) on Core Biopsy, Annals of Surgical Oncology, vol.345, issue.165, pp.66-73, 2014.
DOI : 10.1136/bmj.e4505

D. Allred, G. Clark, and R. Molina, Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer, Human Pathology, vol.23, issue.9, pp.974-983, 1992.
DOI : 10.1016/0046-8177(92)90257-4

A. Perez, R. Rocha, and D. Balabram, Immunohistochemical profile of high-grade ductal carcinoma in situ of the breast, Clinics, vol.68, issue.5, pp.674-682, 2013.
DOI : 10.6061/clinics/2013(05)15

W. Chang, H. Hsu, and J. Yu, Underestimation of invasive lesions in patients with ductal carcinoma in situ of the breast diagnosed by ultrasound-guided biopsy: A comparison between patients with and without HER2/neu overexpression, European Journal of Radiology, vol.83, issue.6, pp.935-976, 2014.
DOI : 10.1016/j.ejrad.2014.02.020

M. Shekhar, I. Kato, and P. Nangia-makker, Comedo-DCIS is a precursor lesion for basal-like breast carcinoma: identification of a novel p63/Her2/neu expressing subgroup, Oncotarget, vol.4, issue.2, pp.231-272, 2013.
DOI : 10.18632/oncotarget.818

K. Siziopikou and S. Khan, Correlation of HER2 Gene Amplification With Expression of the Apoptosis-Suppressing Genes bcl-2 and bcl-x-L in Ductal Carcinoma in Situ of the Breast, Applied Immunohistochemistry & Molecular Morphology, vol.13, issue.1, pp.14-22, 2005.
DOI : 10.1097/00129039-200503000-00003

S. Lee, S. Stewart, and I. Nagtegaal, Differentially Expressed Genes Regulating the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer, Cancer Research, vol.72, issue.17, pp.4574-86, 2012.
DOI : 10.1158/0008-5472.CAN-12-0636